[1]
X. Shi, W. J. Wang, K. J. He, D. C. Wang, X. Q. Li, and X. Li, “Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin”, Gastroenterol Res, vol. 19, no. 5, pp. 295–301, Jan. 2026, doi: 10.14740/gr2193.